Metformin users with Type 2 diabetes had a 39% lower risk of dying in the year after a COVID-19 infection, according to a Stanford study of over 53,000 adults.
Metformin users with Type 2 diabetes had a 39% lower risk of dying in the year after a COVID-19 infection, according to a Stanford study of over 53,000 adults.